Cell Cycle

Cell cycle is the entire process of cell division from the completion of one division to the end of the next division and is divided into two phases: interphase and division. Life is a continuous process passed from generation to generation and is therefore a process of constant renewal and starting from scratch. Thus, it is a process of constant renewal and starting from scratch. The life of a cell begins with the division of its parent cell and ends with the formation of its daughter cells, or the death of the cell itself. Usually, the formation of daughter cells is considered to mark the end of cell division. The cell cycle is the process from the formation of daughter cells at one cell division to the formation of daughter cells at the next cell division. During this process, the genetic material of the cell is copied and distributed equally to the two daughter cells.

Cat. No.	Product name
BP13589	Y16
BP13589	Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.
BP13590	Y16 acetate(429653-73-6 free base)
BP13590	Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.
BP13591	Y-33075 dihydrochloride
BP13591	Y-33075 dihydrochloride is a selective inhibitor of ROCK(IC50 of 3.6 nM).
BP13592	YKL-5-124
BP13592	YKL-5-124, a potent, selective and covalent CDK7 inhibitor with an IC50 of 9.7 nM, 1300 nM and 3020 nM for CDK7/Mat1/CycH, CDK2 and CDK9 respectively, displays biochemical and cellular selectivity for CDK7 over CDK12/13.
BP13593	YM-46303
BP13593	YM-46303 is an antagonist of mAChR
BP13594	ZCL278
BP13594	ZCL278 is a selective Cdc42 GTPase inhibitor.
BP13595	ZD 7155(hydrochloride)
BP13595	ZD 7155 hydrochloride is an antagonist of angiotensin II receptor type 1 (AT1 receptor).
BP13596	ZINC00881524
BP13596	ZINC00881524 is an effective and specific ROCK inhibitor.
BP13597	ZINC69391
BP13597	ZINC69391 is a selective inhibitor of Rac1 with antiproliferative and antimetastatic effects. ZINC69391 interferes with the interaction of Rac1 with Dock180, reduces Rac1-GTP levels and induces apoptosis.
BP13598	ZN-c3
BP13598	ZN-c3 is a potent and selective Wee1 inhibitor with balanced potency, ADME, and pharmacokinetic properties.
BP13599	Zoliflodacin
BP13599	Zoliflodacin (ETX0914, AZD0914) is a new bacterial DNA gyrase/topoisomerase inhibitor. Zoliflodacin has potent in vitro antibacterial activity against Gram-positive and Gram-negative organisms, including S. aureus (MIC90: 0.25 μg/mL).
BP13600	ZYN57939
BP13600	ZYN57939 is RNA polymerase I inhibitor for treating RNA polymerase I- mediated diseases. ZYN57939 showed inhibitory activity with IC50 of 0.855 μM against human HT- 29 cancer cell lines.
BP13601	H-1152 dihydrochloride
BP13601